カテゴリー： QYResearch, 世界

世界の下痢を伴う過敏性腸症候群（IBS-D）薬市場 2019年

【英語タイトル】Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X10088）・商品コード：DATA909X10088
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：108
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、下痢を伴う過敏性腸症候群（IBS-D）薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、序文、エルキサドリン、アロセトロン、リファキシミン、ロペラミド、ジフェノキシレート+アトロピン、ジシクロミン及びヒヨスチアミンに、用途別には、病院、診療所、その他にセグメント区分し、下痢を伴う過敏性腸症候群（IBS-D）薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・下痢を伴う過敏性腸症候群（IBS-D）薬の世界市場概要
・下痢を伴う過敏性腸症候群（IBS-D）薬の製造コスト構成分析
・下痢を伴う過敏性腸症候群（IBS-D）薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・下痢を伴う過敏性腸症候群（IBS-D）薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・下痢を伴う過敏性腸症候群（IBS-D）薬のセグメント分析（種類別）
（序文、エルキサドリン、アロセトロン、リファキシミン、ロペラミド、ジフェノキシレート+アトロピン、ジシクロミン及びヒヨスチアミン）
・下痢を伴う過敏性腸症候群（IBS-D）薬のセグメント分析（用途別）
（病院、診療所、その他）
・下痢を伴う過敏性腸症候群（IBS-D）薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Astellas Pharmaceuticals、Actavis、Pfizer、GlaxoSmithKline、Salix Pharmaceuticals Ltd、AstraZenenca、）
・下痢を伴う過敏性腸症候群（IBS-D）薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Astellas Pharmaceuticals
Actavis
Pfizer
GlaxoSmithKline
Salix Pharmaceuticals Ltd
AstraZenenca
…

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Preface
Eluxadoline
Alosetron
Rifaximin
Loperamide
Diphenoxylate + Atropine
Dicyclomine and Hyoscyamine

Segment by Application
Hospitals
Clinics
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
1.1 Definition of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
1.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segment by Type
1.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Preface
1.2.3 Eluxadoline
1.2.4 Alosetron
1.2.5 Rifaximin
1.2.6 Loperamide
1.2.7 Diphenoxylate + Atropine
1.2.8 Dicyclomine and Hyoscyamine
1.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segment by Applications
1.3.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Overall Market
1.4.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (2014-2025)
1.4.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (2014-2025)
1.4.3 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Status and Prospect (2014-2025)
1.4.4 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Status and Prospect (2014-2025)
1.4.5 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Status and Prospect (2014-2025)
1.4.6 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Status and Prospect (2014-2025)
1.4.8 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
2.3 Manufacturing Process Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
2.4 Industry Chain Structure of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs

3 Development and Manufacturing Plants Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production and Capacity Analysis
4.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Analysis
4.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price Analysis
4.4 Market Concentration Degree

5 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Regional Market Analysis
5.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production by Regions
5.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production by Regions
5.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Regions
5.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption by Regions
5.3 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis
5.3.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production
5.3.2 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Import and Export
5.4 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis
5.4.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production
5.4.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Import and Export
5.5 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis
5.5.1 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production
5.5.2 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Import and Export
5.6 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis
5.6.1 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production
5.6.2 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Import and Export
5.7 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis
5.7.1 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production
5.7.2 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Import and Export
5.8 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis
5.8.1 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production
5.8.2 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Import and Export

6 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segment Market Analysis (by Type)
6.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production by Type
6.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Type
6.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price by Type

7 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segment Market Analysis (by Application)
7.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption by Application
7.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Share by Application (2014-2019)

8 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Manufacturers Analysis
8.1 Astellas Pharmaceuticals
8.1.1 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Sites and Area Served
8.1.2 Astellas Pharmaceuticals Product Introduction, Application and Specification
8.1.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Actavis
8.2.1 Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Sites and Area Served
8.2.2 Actavis Product Introduction, Application and Specification
8.2.3 Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Pfizer
8.3.1 Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Sites and Area Served
8.3.2 Pfizer Product Introduction, Application and Specification
8.3.3 Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 GlaxoSmithKline
8.4.1 GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Sites and Area Served
8.4.2 GlaxoSmithKline Product Introduction, Application and Specification
8.4.3 GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Salix Pharmaceuticals Ltd
8.5.1 Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Sites and Area Served
8.5.2 Salix Pharmaceuticals Ltd Product Introduction, Application and Specification
8.5.3 Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 AstraZenenca
8.6.1 AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Sites and Area Served
8.6.2 AstraZenenca Product Introduction, Application and Specification
8.6.3 AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served

9 Development Trend of Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market
9.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Trend Analysis
9.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Regional Market Trend
9.2.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecast 2019-2025
9.2.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecast 2019-2025
9.2.3 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecast 2019-2025
9.2.4 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecast 2019-2025
9.2.5 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecast 2019-2025
9.2.6 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecast 2019-2025
9.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Trend (Product Type)
9.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Market Share by Types in 2018
Figure Preface Product Picture
Figure Eluxadoline Product Picture
Figure Alosetron Product Picture
Figure Rifaximin Product Picture
Figure Loperamide Product Picture
Figure Diphenoxylate + Atropine Product Picture
Figure Dicyclomine and Hyoscyamine Product Picture
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Share by Applications in 2018
Figure Hospitals
Figure Clinics
Figure Others
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) (2014-2025)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units) (2014-2025)
Figure North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size (Million USD) (2014-2025)
Figure Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size (Million USD) (2014-2025)
Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size (Million USD) (2014-2025)
Figure Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size (Million USD) (2014-2025)
Figure Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size (Million USD) (2014-2025)
Figure India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size (Million USD) (2014-2025)
Table Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs in 2018
Figure Manufacturing Process Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Figure Industry Chain Structure of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Plants Distribution
Table Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity (K Units) of Major Manufacturers (2014-2019)
Table Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units) of Major Manufacturers (2014-2019)
Table Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Market Share of Major Manufacturers (2014-2019)
Figure Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Share by Manufacturers in 2018
Table Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share of Major Manufacturers (2014-2019)
Figure Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Manufacturers in 2018
Table Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production by Regions 2014-2019 (K Units)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Market Share by Regions 2014-2019
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Market Share by Regions in 2018
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Regions 2014-2019 (Million USD)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Regions 2014-2019
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Regions in 2018
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption by Regions 2014-2019 (K Units)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Share by Regions 2014-2019
Figure North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate 2014-2019 (K Units)
Figure North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption Import and Export (K Units)
Figure Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate 2014-2019 (K Units)
Figure Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption Import and Export (K Units)
Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate 2014-2019 (K Units)
Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption Import and Export (K Units)
Figure Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate 2014-2019 (K Units)
Figure Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption Import and Export (K Units)
Figure Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption Import and Export (K Units)
Figure India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate 2014-2019 (K Units)
Figure India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption Import and Export (K Units)
Figure Global Consumption Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application (2014-2019)
Figure Global Value (Consumption) Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application (2014-2019)
Table Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Sites and Area Served
Table Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Introduction, Application and Specification
Table Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate (2014-2019)
Table Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Market Share (2014-2019)
Figure Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share (2014-2019)
Table Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Main Business and Markets Served
Table Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Sites and Area Served
Table Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Introduction, Application and Specification
Table Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate (2014-2019)
Table Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Market Share (2014-2019)
Figure Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share (2014-2019)
Table Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Main Business and Markets Served
Table Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Sites and Area Served
Table Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Introduction, Application and Specification
Table Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate (2014-2019)
Table Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Market Share (2014-2019)
Figure Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share (2014-2019)
Table Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Main Business and Markets Served
Table GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Sites and Area Served
Table GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Introduction, Application and Specification
Table GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate (2014-2019)
Table GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Market Share (2014-2019)
Figure GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share (2014-2019)
Table GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Main Business and Markets Served
Table Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Sites and Area Served
Table Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Introduction, Application and Specification
Table Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate (2014-2019)
Table Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Market Share (2014-2019)
Figure Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share (2014-2019)
Table Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Main Business and Markets Served
Table AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Sites and Area Served
Table AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Introduction, Application and Specification
Table AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate (2014-2019)
Table AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Market Share (2014-2019)
Figure AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share (2014-2019)
Table AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Main Business and Markets Served
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type (2019-2025)
Table Global Consumption (K Units) of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Application (2019-2025)
Table Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Distributors List
Table Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Astellas Pharmaceuticals、Actavis、Pfizer、GlaxoSmithKline、Salix Pharmaceuticals Ltd、AstraZenenca、

★調査レポート[世界の下痢を伴う過敏性腸症候群（IBS-D）薬市場 2019年] (コード：DATA909X10088)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の下痢を伴う過敏性腸症候群（IBS-D）薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の便秘薬による過敏性腸症候群市場 2019年
    DATA909X10087 / QYResearch / 2019年11月20日 / ※本調査レポートは、便秘薬による過敏性腸症候群の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ルビプロストン、リナクロチド、覚せい剤下剤、浸透圧性下剤、その他に、用途別には、病院、診療所、その他にセグメント区分し、便秘薬による過敏性腸症候群の世界市場を分析しました。 ・エグゼクティブ・サマリー ・便秘薬による過敏性腸症候群の世界市場概要 ・便秘薬による過敏性腸症候群の製造コスト構成分析 ・便秘薬による過敏性腸症候群の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・便秘薬による過敏性腸症候群の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・便秘薬による過敏性腸症候群のセグメント分析（種類別） （ルビプロストン、リナクロチド、覚せい剤下剤、浸透圧性下剤、その他）...The global Irritable Bowel Syndrome with Constipation Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Irritable Bowel Syndrome with Constipation Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Irritable Bowel Syndrome with Constipation Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Irritable Bowel Syndrome with Constipation Drugs in North America, Europe, China,...
  • 世界の多嚢胞性卵巣症候群（PCOS）治療薬市場 2019年
    DATA909X13285 / QYResearch / 2019年11月20日 / ※本調査レポートは、多嚢胞性卵巣症候群（PCOS）治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、経口避妊薬、抗炎症薬、インスリン抵抗性改善薬、抗高血圧薬、抗肥満薬に、用途別には、病院、クリニックにセグメント区分し、多嚢胞性卵巣症候群（PCOS）治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・多嚢胞性卵巣症候群（PCOS）治療薬の世界市場概要 ・多嚢胞性卵巣症候群（PCOS）治療薬の製造コスト構成分析 ・多嚢胞性卵巣症候群（PCOS）治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・多嚢胞性卵巣症候群（PCOS）治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・多嚢胞性卵巣症候群（PCOS）治療薬のセグメント分析（種類別） （経口避妊薬、抗炎症薬、インスリン抵抗性改善薬、抗高血圧薬、抗肥満薬）...The global Polycystic Ovary Syndrome (PCOS) Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Polycystic Ovary Syndrome (PCOS) Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Polycystic Ovary Syndrome (PCOS) Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Polycystic Ovary Syndrome (PCOS) Drugs in North America, Europe, China, Japan, Southeast Asia and...
  • 世界のドライアイ症候群薬市場 2019年
    DATA909X06827 / QYResearch / 2019年11月15日 / ※本調査レポートは、ドライアイ症候群薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、抗生物質ドロップ、ホルモンドロップ、人工涙液、その他に、用途別には、病院、診療所、家庭用、その他にセグメント区分し、ドライアイ症候群薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ドライアイ症候群薬の世界市場概要 ・ドライアイ症候群薬の製造コスト構成分析 ・ドライアイ症候群薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ドライアイ症候群薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ドライアイ症候群薬のセグメント分析（種類別） （抗生物質ドロップ、ホルモンドロップ、人工涙液、その他）...The global Dry Eye Syndrome Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Dry Eye Syndrome Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Dry Eye Syndrome Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Dry Eye Syndrome Drugs in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界のギランバレー症候群薬市場 2019年
    DATA909X08653 / QYResearch / 2019年11月15日 / ※本調査レポートは、ギランバレー症候群薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、Coversin、免疫グロブリン、その他に、用途別には、クリニック、病院、その他にセグメント区分し、ギランバレー症候群薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ギランバレー症候群薬の世界市場概要 ・ギランバレー症候群薬の製造コスト構成分析 ・ギランバレー症候群薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ギランバレー症候群薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ギランバレー症候群薬のセグメント分析（種類別） （Coversin、免疫グロブリン、その他）...The global Guillain-Barre Syndrome Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Guillain-Barre Syndrome Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Guillain-Barre Syndrome Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Guillain-Barre Syndrome Drugs in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の炎症性腸疾患治療市場 2019年
    DATA909X09776 / QYResearch / 2019年11月20日 / ※本調査レポートは、炎症性腸疾患治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アミノサリチル酸塩、TNF阻害剤、コルチコステロイド、免疫調節剤に、用途別には、小売薬局、病院薬局、オンライン薬局にセグメント区分し、炎症性腸疾患治療の世界市場を分析しました。 ・エグゼクティブ・サマリー ・炎症性腸疾患治療の世界市場概要 ・炎症性腸疾患治療の製造コスト構成分析 ・炎症性腸疾患治療の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・炎症性腸疾患治療の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・炎症性腸疾患治療のセグメント分析（種類別） （アミノサリチル酸塩、TNF阻害剤、コルチコステロイド、免疫調節剤）...The global Inflammatory Bowel Disease Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Inflammatory Bowel Disease Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Inflammatory Bowel Disease Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Inflammatory Bowel Disease Treatment in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の豚流行性下痢ワクチン市場 2019年
    DATA909X13445 / QYResearch / 2019年11月20日 / ※本調査レポートは、豚流行性下痢ワクチンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、生ワクチン、殺ワクチンに、用途別には、子豚、成豚にセグメント区分し、豚流行性下痢ワクチンの世界市場を分析しました。 ・エグゼクティブ・サマリー ・豚流行性下痢ワクチンの世界市場概要 ・豚流行性下痢ワクチンの製造コスト構成分析 ・豚流行性下痢ワクチンの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・豚流行性下痢ワクチンの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・豚流行性下痢ワクチンのセグメント分析（種類別） （生ワクチン、殺ワクチン）...The global Porcine Epidemic Diarrhea Vaccines market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Porcine Epidemic Diarrhea Vaccines volume and value at global level, regional level and company level. From a global perspective, this report represents overall Porcine Epidemic Diarrhea Vaccines market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Porcine Epidemic Diarrhea Vaccines in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界のトゥレット症候群薬市場 2019年
    DATA909X16695 / QYResearch / 2019年11月22日 / ※本調査レポートは、トゥレット症候群薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、AZD-5213、CPP-115、デューテトラベナジンER、エコピパム塩酸塩、その他に、用途別には、研究センター、病院、クリニック、その他にセグメント区分し、トゥレット症候群薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・トゥレット症候群薬の世界市場概要 ・トゥレット症候群薬の製造コスト構成分析 ・トゥレット症候群薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・トゥレット症候群薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・トゥレット症候群薬のセグメント分析（種類別） （AZD-5213、CPP-115、デューテトラベナジンER、エコピパム塩酸塩、その他）...The global Tourette Syndrome Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Tourette Syndrome Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tourette Syndrome Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Tourette Syndrome Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

    • ◆H&Iグローバルリサーチのお客様（例）◆